Skip to main content

Spotting the Study Design

Spotting the Study Design


We can work the type of study by looking at three issues:

Assigning exposures

Will you “assign” exposures? 

If you assign exposure—which might be an intervention, like an antidepressant, a placebo, or a therapy, for example—you are doing an experimental (intervention before observation) study. 

Observational (no intervention involved) 

Experimental designs 

Will there be a control group? Controlled study.

Will there be an active comparator or placebo? 

Some trials use an active comparator, and we call it active comparator trial. if you want to you a placebo, your study design is a placebo-control trial. 

will the allocation be random?  

yes > randomised

no > non-randomised/quasi-experimental   

Will the allocation be swapped from time to time? Yes -> cross-over, No ->  parallel

Who will know about the allocation of the treatment? 

         Everyone -> open-label

         All except patients > single-blinded

         Neither patients nor assessors -> double-blinded

Observational study designs

-> will there be a comparison group?

Yes -> analytical (if you want to test a hypothesis, choose this one) 

No -> descriptive study 

---

> Analytical study designs

Want to determine the outcome of exposure -> cohort (begins with exposure) 

Exposure has occurred in the past and is tracked down till date -> retrospective cohort

Exposure will occur from now onward and will be followed over time -> prospective cohort 

Want to determine the (causes of/factors-affecting the) outcome -> case-control (begins with the outcome/cases) 

---

Want to determine/identify certain factors in a population at an instance? -> Cross-sectional surveys 

comparison group present? -> analytical, otherwise observational

---

Want to determine the prevalence of depression in teachers? -> cross-sectional survey, observational

Want to determine whether physical punishment will lead to poor academic performance in students? 

 -> either retrospective cohort (punishment received traced till date, better choice, beware bias (students with poor academics more likely to be punished) or case control (academically poor students vs talented students, beware of bias). Don’t choose a prospective cohort, we can not let children be exposed to punishment while conducting research. 

Want to test new drug but do not want to harm patients, choose active comparator.

Want to determine the incidence of disease in a particular group, choose prospective cohort. One sample from that group and another comparison group.

Want to determine the risk of cancer in smokers? Choose cohort. 

(Point) Prevalence of depression in diabetes? Cross-sectional 

10-year prevalence of depression in diabetes? Prospective cohort.   

Factors associated with depression in diabetes? Case-control. 

CBT versus clinical management? Open label. 

ECT efficacy, bright light therapy? Sham comparator. 

---

We should finally note that studies can incorporate several design elements. For example, the control arm of a randomised trial may also be used as a cohort study; and we may use the baseline measures of a cohort study as a cross-sectional study.




 




---




To simply describe a population (PO questions) 

descriptive

To quantify the relationship between factors (PICO questions) 

analytic.

was the intervention randomly allocated?

Yes? 

RCT

No? 

Observational study

For observational study the main types will then depend on the timing of the measurement of outcome, so our third question is:

Q3. When were the outcomes determined?

Some time after the exposure or intervention?

 cohort study (‘prospective study’)

At the same time as the exposure or intervention?  

 cross sectional study or survey

Before the exposure was determined? 

case-control study (‘retrospective study’ based on recall of the exposure)




For example, if you want to determine the prevalence of depression in teachers, it should be descriptive, observational, cross-sectional study design. 

Comments

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)

ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05

ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05 Attention deficit hyperactivity disorder is characterised by a persistent pattern (at least 6 months) of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning. There is evidence of significant inattention and/or hyperactivity-impulsivity symptoms prior to age 12, typically by early to mid-childhood, though some individuals may first come to clinical attention later. The degree of inattention and hyperactivity-impulsivity is outside the limits of normal variation expected for age and level of intellectual functioning. Inattention refers to significant difficulty in sustaining attention to tasks that do not provide a high level of stimulation or frequent rewards, distractibility and problems with organisation. Hyperactivity refers to excessive motor activity and difficulties with remaining still, most evident in structured situations that re...

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71 Recurrent depressive disorder is characterised by a history or at least two depressive episodes separated by at least several months without significant mood disturbance. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a Bipolar disorder. Inclusions:                Seasonal depressive disorder Exclusions:    ...